Curative Biotechnology, Inc.
CUBT
$0.0099
$0.000.00%
OTC PK
| 03/31/2025 | 03/31/2024 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 258.90K | 729.50K | 407.70K | 747.60K | 373.80K |
| Depreciation & Amortization | 21.90K | 26.40K | 2.00K | 2.00K | 2.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 282.50K | 761.60K | 963.40K | 1.29M | 934.00K |
| Operating Income | -282.50K | -761.60K | -963.40K | -1.29M | -934.00K |
| Income Before Tax | -481.60K | -1.11M | -1.29M | -1.40M | -935.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -481.60K | -1.11M | -1.29M | -1.40M | -935.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -481.60K | -1.11M | -1.29M | -1.40M | -935.90K |
| EBIT | -282.50K | -761.60K | -963.40K | -1.29M | -934.00K |
| EBITDA | -260.60K | -735.20K | -961.40K | -1.29M | -933.90K |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 932.10M | 903.26M | 571.65M | 571.50M | 566.62M |
| Average Diluted Shares Outstanding | 932.10M | 903.26M | 571.65M | 571.50M | 566.62M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |